NDC’s key investment project, Glovax, aimed to be incentivized with EO 18 by the BOI

Glovax, the Philippines' first planned vaccine manufacturing plant, recently had a courtesy meeting with the Philippine Board of Investments (BOI), represented by Usec. Ceferino 'Perry' Rodolfo, BOI Vice Chairman and Managing Head.

As discussed in the meeting, the BOI aims to provide Glovax project incentives via the Executive Order No. 18, Constituting Green Lanes for Strategic Investments. This would expedite the government process for this particular strategic investment.

National Development Company, the government’s key investor in the project, was present together with potential strategic financiers, the Plenary Group from Australia and Singapore, and the Asian Development Bank (ADB).

This is a significant milestone for the country's healthcare industry, and NDC looks forward to seeing the positive impact of this project on our society.